Title: President and CEO
Company: WRECON, Inc.
Location: Laguna Hills, California, United States
Bryant W. Rossiter, PhD, president and chief executive officer of WRECON, Inc., has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in chemistry and research.
Attributing his achievements to his journey of lifelong learning and eagerness to apply his research to world needs, Dr. Rossiter has met tremendous success since establishing his career in 1953. He came to choose a career in chemistry when, at age ten, his parents gave him a “Gilbert Chemistry Set.” Early experiments and youthful explorations in the basement of their family home unleashed a series of obnoxious smells and explosive sounds as well as desire to conduct chemical research for the enjoyment and benefit of mankind. After serving in the U.S. Air Force during the Korean War and spending seven subsequent years as a first lieutenant for the U.S. Air Force Reserve, he turned his career to his passion for physical methods and chemical experimentation. Among Dr. Rossiter’s responsibilities was the management of Phase II clinical trials for the broad-spectrum antiviral agent, Ribavirin, targeted for the treatment of AIDS, influenza, hepatitis C, and a number of other viral disease indications. Today, Ribavirin is known worldwide for the treatment of respiratory syncytial virus and hepatitis C. In addition, his expansive research led to an understanding of the fundamental chemical processes underlying photographic dye formation and the light and dark degradation of color photographic images. Over the course of five decades, Dr. Rossiter has worked with more than 200 research scientists and he has published countless articles to scientific journals and texts. Most notably, he was the editor of 11 editions of “Physical Methods of Chemistry,” as well as the text “Chemical Experimentation Under Extreme Conditions.”
Before coming into his role with WRECON, Inc., Dr. Rossiter held prominent roles including senior vice president of ICN Pharmaceuticals and president of Viratek Inc, where he specialized in joint venture development, drug discovery and conducting clinical trials. He also held numerous positions with Eastman Kodak Company, where he was responsible for much of its pioneering and long-range research. His roles for the company included director of science and technology development, director of the chemistry division, head of the color physical chemical laboratory, and researcher. He has directed fundamental and applied research related to color photographic product development. Dr. Rossiter’s experience and expertise is supported by his education and his professional affiliations. He holds a Bachelor of Arts and a PhD in chemistry with minors in physics from the University of Utah. His PhD dissertation was titled Synthesis of Natural Products. He is a member of the American Chemical Society, where he previously served as chairman of International activities.
Dr. Rossiter has also been very involved with IUPAC, where he held numerous positions including chairman of the committee for chemical research applied to world needs, chairman of the U.S. National Committee, and chairman of the International Conference on Chemistry and World Food Supplies. His achievements include building the work and prominence of the Church of Jesus Christ of Latter-Day Saints, establishing a joint venture with ICN Pharmaceuticals leading to FDA approval of Ribavirin for the treatment of hepatitis, establishing CHEMRAWN (CHEMIXCAL Research Applied to World Needs), and the elucidation of fundamental reactions underlying the formation and the light and dark degradation of photographic dyes. Of all these accomplishments, Dr. Rossiter prides himself of being a devoted husband and father who valued truth wherever he found it both on religious or scientific grounds.
For more information, please visit:
Contact Dr. Rossiter: